On September 29, 2023, the FDA is hosting a hybrid listening session to obtain feedback about topics related to modernizing recalls of FDA-regulated food, beverage and supplement products. The agency is inviting comments from all interested stakeholders.
Panelists at the IAFP Conference “From Bench-top to Scale Up: The Unspoken Food Safety Challenges of Research and Development” session highlighted areas of regulatory and food safety risk during R&D, as well as potential solutions to prevent delays in bringing new products to market.
Food safety and quality professionals can take advantage of three days of education, networking and panel discussions at the 11th Annual Food Safety Consortium, October 16-18 in Parsippany, New Jersey. This year’s event is co-located with the Cannabis Quality Conference and Food Defense Consortium.
Undeclared allergens are the leading cause of food and beverage recalls. While government regulations aim to protect individuals with food allergies by requiring food labels to disclose ingredients, the fast-paced and ever-changing landscape of food regulation creates opportunities for risks such as allergen cross-contact. By developing an Allergen Management Program, businesses can lessen the risk of costly contaminations, recalls and reputational damage.
The 120 Day Food and Agriculture Interim Risk Review provides a review of critical and emergent risks facing the U.S. Food and Agriculture sector, as well initial mitigation strategies, factors contributing to risk and proposed actions to address risks.
Infant food safety, including new arsenic and cadmium action levels, supplements and menu labeling, are among the priority draft and final guidances the FDA plans to address before the end of 2023.
Real-time supply chain monitoring helps brands optimize operations, safety, efficiency, and performance throughout the supply chain. By leveraging real-time data, organizations can identify potential disruptions in the supply chain and take prompt, proactive measures to address and resolve them.
In June, the USDA FSIS granted label approval and grant of inspection to two companies manufacturing cell-cultured meat: Upside Foods and Good Meat. This was the final step in the U.S. regulatory process, opening the door for commercialization. We spoke with Justin Dranschak, Director of BioPharma at Molecular Devices, about a potential timeline to sales, what this means for other manufacturers of lab-grown meat products and what impact these products may have on the U.S. and international food supply.
The updated action plan includes refined strategies, a report on accomplishments and three new actions that have been identified by the task force: advancing root cause analyses procedures, building a repository of Cyclospora oocysts that can be used for research and advancing the methods to conduct such research.
This article explores the multifaceted nature of website and social media images related to food safety and marketing, focusing on its impact on accountability, brand reputation, liability, adherence to the FDA Food Code regulations and legal ramifications.
